Degludec-Glargine Hospital Trial: A Randomized Controlled Trial Comparing Insulin and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2018
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Oct 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 02 Oct 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Jun 2019.
- 31 Aug 2018 Biomarkers information updated